Neuroleptic-potentiating effect of metyrosine.
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004357:Drug Synergism; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008781:Methyltyrosines / Q000627:therapeutic use*; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*
D014150:Antipsychotic Agents; D008781:Methyltyrosines; D006220:Haloperidol